Over $1 Billion Won
For Our Clients

Our Blog

Are “Cannabis-Derived Drugs” Safe?

After shedding marijuana’s “dangerous narcotic” reputation, cannabis-derived drugs are slowly entering the marketplace. However, these drugs are not without known risks.

Class Action versus Single Plaintiff Zantac Lawsuits

Class Action versus Single Plaintiff Zantac Lawsuits As we discussed in a previous post, the Food and Drug Administration has ordered a recall of the popular antacid drug Zantac (ranitidine) after it was found to contain significant levels of the cancer-causing substance NDMA. Since that post we have received numerous questions from cancer victims and their families asking us if they should participate in a class action lawsuit against Zantac’s manufacturers. In today’s post the dangerous drug lawyer at The…

If You’re a Zantac User, Protect Your Health – And Your Legal Rights

If You’re a Zantac User, Protect Your Health – And Your Legal Rights The U.S. Food and Drug Administration (FDA) took the extraordinary step in March of immediately ordering the removal of over-the-counter Zantac and its prescription counterpart from shelves. Consumers have been directed to stop using Zantac immediately. The FDA announced that it is possible that a dose of Zantac (both the over-the-counter and prescription versions of the product) may contain over 3,000-times the limit of a substance called…

FDA Issues Voluntary Manufacturers’ Recall of Antacid Drug, Zantac

The Food and drug Administration has issued a voluntary recall order affecting the popular stomach acid blocker ranitidine (“Zantac”) after the drug was found to contain the known cancer-causing substance NDMA. In today’s post our dangerous drugs lawyer explains how this recall could lead to hundreds of dangerous/defective drug lawsuits filed by those who developed cancer after taking Zantac.

FDA Orders Leading Heartburn Medication Zantac Immediately Pulled from Market Citing Cancer Danger

FDA Orders Leading Heartburn Medication Zantac Immediately Pulled from Market Citing Cancer Danger The U.S. Food and Drug Administration, FDA, took the rare and dramatic step of immediately ordering the widely used heartburn medicine Zantac removed from the market on April 1, 2020. Zantac is the brand name for ranitidine, the primary element of both prescription and over-the-counter versions of this medication. In addition, all generic forms of this drug were ordered off the market by the FDA as well….

Request Free Consultation

Tell us about what happened

Categories

Contact Us
Request Your Free Consultation and Our Lawyer Will Contact You Within 1 Hour

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
This field is for validation purposes and should be left unchanged.

* Required Field